Finerenone in Patients with CKD and T2D by SGLT2i Treatment: An Analysis of the FIDELIO-DKD Study

被引：0
|
作者：
Rossing, Peter
Agarwal, Rajiv
Anker, Stefan
Filippatos, Gerasimos
Pitt, Bertram
Ruilope, Luis M.
Chan, Juliana C.
Kooy, Adriaan
Mccafferty, Kieran
Schernthaner, Guntram
Wanner, Christoph
Joseph, Amer
Scheerer, Markus F.
Scott, Charlie
Bakris, George
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-14-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14-LB
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data
    Yu, Samuel Mon-Wei
    Leventhal, Jeremy S.
    Cravedi, Paolo
    JOURNAL OF NEPHROLOGY, 2021, 34 (03) : 629 - 631
  • [42] SGLT2i in CKD with high albuminuria: an observational real-world study
    Svensson, Maria K.
    Bodegard, Johan
    Thuresson, Marcus
    Ambery, Philip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I263 - I264
  • [43] SGLT2i in CKD with high albuminuria: an observational real-world study
    Svensson, Maria K.
    Bodegard, Johan
    Thuresson, Marcus
    Ambery, Philip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [44] Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data
    Samuel Mon-Wei Yu
    Jeremy S. Leventhal
    Paolo Cravedi
    Journal of Nephrology, 2021, 34 : 629 - 631
  • [45] Glucose Lowering with an SGLT2I Improves Trabecular Bone but Does Not Correct Bone Brittleness in TallyHo Model of T2D
    Thrailkill, Kathryn M.
    Bunn, R. Clay
    Uppuganti, Sasidhar
    Ray, Philip D.
    Popescu, Iuliana
    Kalaitzoglou, Evangelia
    Fowlkes, John
    Nyman, Jeffry S.
    DIABETES, 2019, 68
  • [46] Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study (vol 45, pg 888, 2022)
    Rossing, Peter
    Burgess, Ellen
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Gillard, Pieter
    MacIsaac, Richard J.
    Wainstein, Julio
    Joseph, Amer
    Brinker, Meike
    Roessig, Lothar
    Scott, Charlie
    Bakris, George L.
    FIDELIO DKD Investigators
    DIABETES CARE, 2023, 46 (09) : 1721 - 1721
  • [47] The effect of SGLT2i on the GH/IGF1 axis in newly diagnosed male T2D patients - a prospective, randomized case-control study
    Lin, Jing
    Zhan, Liqin
    Chen, Zheng
    Lin, Xiaying
    Zhu, Rongfeng
    ENDOCRINE, 2024, 84 (01) : 203 - 212
  • [48] Risk of CKD among patients with DM taking diuretics or SGLT2i: a retrospective cohort study in Taiwan
    Lin, Han-Jie
    Shih, Pin-Yang
    Tsai, Stella Chin-Shaw
    Chuang, Wu-Lung
    Hsieh, Tsai-Ling
    Lin, Heng-Jun
    Yu, Teng-Shun
    Tsai, Fuu-Jen
    Chen, Chiu-Ying
    Chang, Kuang-Hsi
    BMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01):
  • [49] Comparison the effects of finerenone and SGLT2i on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus: A network meta-analysis
    Li, Xuefeng
    Wu, Hongli
    Peng, Huifang
    Jiang, Hongwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [50] Diabetic Kidney Disease (DKD) in UK Patients With Type 2 Diabetes (T2D)
    Ruzafa, Javier Cid
    Paczkowski, Rosirene
    Boye, Kristina S.
    Di Tanna, Gian Luca
    Sheetz, Matthew J.
    Donaldson, Robert
    Breyer, Matthew D.
    Neasham, David
    Voelker, James R.
    DIABETES, 2013, 62 : A397 - A397
12345